Cepheid, a California-based medical device firm, has received market authorization from the US Food & Drug Administration (FDA) for its Xpert MTB/RIF test, a tuberclosis test. The regulatory agency approved following a de novo 510(k) ...
Tags: Cephid, Tuberclosis Test